Harsukh Parmar, USA



Harsukh completed his medical training at Aberdeen University and post-graduate clinical, academic and research training in internal medicine, immunology & oncology at Westminster & Charing Cross Hospitals, London (Imperial Medical School). He joined Pfizer Central Research in 1994 in the Dept of Experimental Medicine as Clinical Project Manager/Associate Director. Later he joined Roche Global Drug Development as Global Clinical Science Leader,  Director of Oncology and worked on various projects in oncology, virology, and immunology.  In 1998 he joined AstraZeneca as Director, Global Experimental Medicine, R & D Charnwood and in 2003 took on the additional role of Director, Global Discovery Medicine, Respiratory  & Inflammation Therapeutic Area and  VP & Global Head of Early Clinical development for the Respiratory & Inflammation Therapy Area. He  also served on the AZ, Global Human Exposure Limits Committee (HELC), which oversaw all compounds that enter FTIM, entry into children and women of child bearing age. In 2011 he rejoined Roche as VP, Global Head of Translational & Experimental Medicine and in 2013 joined Merck KGa as SVP, Global Head of Research & Early Development, Immunology & Neurology. He has published extensively (> 100 publications) and has been an invited keynote speaker at more than 100 international conferences and is cited in the Marquis Who Who for “demonstrating outstanding achievement” and “contributing significantly to the betterment of contemporary society”.